HEADER TRANSFERASE/TRANSFERASE INHIBITOR 19-AUG-13 4MBJ TITLE HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH AN IMIDAZOPYRIDINE-BASED TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE B-RAF; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: PROTEIN KINASE DOMAIN (UNP RESIDUES 432-723); COMPND 5 SYNONYM: PROTO-ONCOGENE B-RAF, P94, V-RAF MURINE SARCOMA VIRAL COMPND 6 ONCOGENE HOMOLOG B1; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRAF, BRAF1, RAFB1; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.C.VOEGTLI REVDAT 3 28-FEB-24 4MBJ 1 REMARK SEQADV REVDAT 2 06-NOV-13 4MBJ 1 JRNL REVDAT 1 02-OCT-13 4MBJ 0 JRNL AUTH B.J.NEWHOUSE,S.WENGLOWSKY,J.GRINA,E.R.LAIRD,W.C.VOEGTLI, JRNL AUTH 2 L.REN,K.AHRENDT,A.BUCKMELTER,S.L.GLOOR,N.KLOPFENSTEIN, JRNL AUTH 3 J.RUDOLPH,Z.WEN,X.LI,B.FENG JRNL TITL IMIDAZO[4,5-B]PYRIDINE INHIBITORS OF B-RAF KINASE. JRNL REF BIOORG.MED.CHEM.LETT. V. 23 5896 2013 JRNL REFN ISSN 0960-894X JRNL PMID 24042006 JRNL DOI 10.1016/J.BMCL.2013.08.086 REMARK 2 REMARK 2 RESOLUTION. 3.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 10724 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.276 REMARK 3 FREE R VALUE : 0.328 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.100 REMARK 3 FREE R VALUE TEST SET COUNT : 659 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4366 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 61.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.03600 REMARK 3 B22 (A**2) : -0.03600 REMARK 3 B33 (A**2) : 0.07100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.598 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.954 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.413 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.517 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : AR00455401.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4MBJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-AUG-13. REMARK 100 THE DEPOSITION ID IS D_1000081706. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10739 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.600 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08500 REMARK 200 FOR THE DATA SET : 8.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.36600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.73 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG8000, PH 8.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 76.22000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 53.48500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 53.48500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 38.11000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 53.48500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 53.48500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 114.33000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 53.48500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 53.48500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 38.11000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 53.48500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 53.48500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 114.33000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 76.22000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2220 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25270 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 420 REMARK 465 ASP A 421 REMARK 465 ARG A 422 REMARK 465 GLY A 423 REMARK 465 SER A 424 REMARK 465 HIS A 425 REMARK 465 HIS A 426 REMARK 465 HIS A 427 REMARK 465 HIS A 428 REMARK 465 HIS A 429 REMARK 465 HIS A 430 REMARK 465 GLY A 431 REMARK 465 SER A 432 REMARK 465 GLU A 433 REMARK 465 ASP A 434 REMARK 465 ARG A 435 REMARK 465 ASN A 436 REMARK 465 ARG A 437 REMARK 465 MET A 438 REMARK 465 LYS A 439 REMARK 465 THR A 440 REMARK 465 LEU A 441 REMARK 465 GLY A 442 REMARK 465 ARG A 443 REMARK 465 ARG A 444 REMARK 465 ASP A 445 REMARK 465 SER A 446 REMARK 465 SER A 447 REMARK 465 GLY A 606 REMARK 465 SER A 607 REMARK 465 HIS A 608 REMARK 465 GLN A 609 REMARK 465 PHE A 610 REMARK 465 GLU A 611 REMARK 465 GLN A 612 REMARK 465 MET B 420 REMARK 465 ASP B 421 REMARK 465 ARG B 422 REMARK 465 GLY B 423 REMARK 465 SER B 424 REMARK 465 HIS B 425 REMARK 465 HIS B 426 REMARK 465 HIS B 427 REMARK 465 HIS B 428 REMARK 465 HIS B 429 REMARK 465 HIS B 430 REMARK 465 GLY B 431 REMARK 465 SER B 432 REMARK 465 GLU B 433 REMARK 465 ASP B 434 REMARK 465 ARG B 435 REMARK 465 ASN B 436 REMARK 465 ARG B 437 REMARK 465 MET B 438 REMARK 465 LYS B 439 REMARK 465 THR B 440 REMARK 465 LEU B 441 REMARK 465 GLY B 442 REMARK 465 ARG B 443 REMARK 465 ARG B 444 REMARK 465 ASP B 445 REMARK 465 SER B 446 REMARK 465 SER B 447 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 463 -46.77 -150.18 REMARK 500 PHE A 468 -29.44 87.68 REMARK 500 TRP A 476 102.35 -163.79 REMARK 500 ASN A 486 42.04 27.15 REMARK 500 ALA A 489 119.93 59.23 REMARK 500 THR A 491 47.61 88.80 REMARK 500 GLN A 493 49.18 -100.98 REMARK 500 LYS A 522 -78.31 -76.44 REMARK 500 GLN A 524 -167.33 -115.03 REMARK 500 GLN A 530 154.32 -46.23 REMARK 500 SER A 535 -131.49 -86.25 REMARK 500 LYS A 570 40.63 -103.37 REMARK 500 ARG A 575 -7.47 71.40 REMARK 500 ASP A 576 56.83 -161.16 REMARK 500 LYS A 578 153.71 171.30 REMARK 500 GLU A 586 17.46 52.15 REMARK 500 ASP A 587 -8.37 82.22 REMARK 500 ASP A 594 45.25 -92.89 REMARK 500 LEU A 597 -130.33 62.29 REMARK 500 ALA A 598 -55.13 86.17 REMARK 500 VAL A 600 48.09 -105.04 REMARK 500 LYS A 601 -35.14 -158.56 REMARK 500 SER A 614 -65.98 173.82 REMARK 500 MET A 627 93.27 -61.66 REMARK 500 ASP A 629 -132.00 -152.25 REMARK 500 LEU A 678 1.72 -57.57 REMARK 500 VAL A 681 108.96 -57.85 REMARK 500 SER A 683 -53.45 3.99 REMARK 500 ARG A 719 17.85 -64.46 REMARK 500 LEU A 721 -49.98 -157.79 REMARK 500 PRO A 722 8.94 -63.28 REMARK 500 ILE B 463 -42.00 -147.43 REMARK 500 TRP B 476 102.59 -163.22 REMARK 500 ASN B 486 40.11 27.46 REMARK 500 ALA B 489 120.44 59.79 REMARK 500 THR B 491 48.61 88.28 REMARK 500 GLN B 493 48.53 -101.75 REMARK 500 LYS B 522 -77.73 -78.08 REMARK 500 GLN B 524 -167.07 -117.00 REMARK 500 GLN B 530 155.78 -47.44 REMARK 500 SER B 535 -130.08 -88.02 REMARK 500 ILE B 543 -60.53 -93.32 REMARK 500 ARG B 575 -7.37 76.66 REMARK 500 ASP B 576 54.06 -162.92 REMARK 500 LYS B 578 153.94 171.05 REMARK 500 GLU B 586 17.30 50.70 REMARK 500 ASP B 587 -5.86 82.09 REMARK 500 ASP B 594 47.42 -95.18 REMARK 500 LEU B 597 -132.00 60.90 REMARK 500 ALA B 598 -56.73 88.36 REMARK 500 REMARK 500 THIS ENTRY HAS 63 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ILE A 592 GLY A 593 -149.39 REMARK 500 ILE B 592 GLY B 593 -148.76 REMARK 500 GLN B 612 LEU B 613 136.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DFS A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DFS B 801 DBREF 4MBJ A 432 723 UNP P15056 BRAF_HUMAN 432 723 DBREF 4MBJ B 432 723 UNP P15056 BRAF_HUMAN 432 723 SEQADV 4MBJ MET A 420 UNP P15056 EXPRESSION TAG SEQADV 4MBJ ASP A 421 UNP P15056 EXPRESSION TAG SEQADV 4MBJ ARG A 422 UNP P15056 EXPRESSION TAG SEQADV 4MBJ GLY A 423 UNP P15056 EXPRESSION TAG SEQADV 4MBJ SER A 424 UNP P15056 EXPRESSION TAG SEQADV 4MBJ HIS A 425 UNP P15056 EXPRESSION TAG SEQADV 4MBJ HIS A 426 UNP P15056 EXPRESSION TAG SEQADV 4MBJ HIS A 427 UNP P15056 EXPRESSION TAG SEQADV 4MBJ HIS A 428 UNP P15056 EXPRESSION TAG SEQADV 4MBJ HIS A 429 UNP P15056 EXPRESSION TAG SEQADV 4MBJ HIS A 430 UNP P15056 EXPRESSION TAG SEQADV 4MBJ GLY A 431 UNP P15056 EXPRESSION TAG SEQADV 4MBJ MET B 420 UNP P15056 EXPRESSION TAG SEQADV 4MBJ ASP B 421 UNP P15056 EXPRESSION TAG SEQADV 4MBJ ARG B 422 UNP P15056 EXPRESSION TAG SEQADV 4MBJ GLY B 423 UNP P15056 EXPRESSION TAG SEQADV 4MBJ SER B 424 UNP P15056 EXPRESSION TAG SEQADV 4MBJ HIS B 425 UNP P15056 EXPRESSION TAG SEQADV 4MBJ HIS B 426 UNP P15056 EXPRESSION TAG SEQADV 4MBJ HIS B 427 UNP P15056 EXPRESSION TAG SEQADV 4MBJ HIS B 428 UNP P15056 EXPRESSION TAG SEQADV 4MBJ HIS B 429 UNP P15056 EXPRESSION TAG SEQADV 4MBJ HIS B 430 UNP P15056 EXPRESSION TAG SEQADV 4MBJ GLY B 431 UNP P15056 EXPRESSION TAG SEQRES 1 A 304 MET ASP ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER SEQRES 2 A 304 GLU ASP ARG ASN ARG MET LYS THR LEU GLY ARG ARG ASP SEQRES 3 A 304 SER SER ASP ASP TRP GLU ILE PRO ASP GLY GLN ILE THR SEQRES 4 A 304 VAL GLY GLN ARG ILE GLY SER GLY SER PHE GLY THR VAL SEQRES 5 A 304 TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA VAL LYS MET SEQRES 6 A 304 LEU ASN VAL THR ALA PRO THR PRO GLN GLN LEU GLN ALA SEQRES 7 A 304 PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS THR ARG HIS SEQRES 8 A 304 VAL ASN ILE LEU LEU PHE MET GLY TYR SER THR LYS PRO SEQRES 9 A 304 GLN LEU ALA ILE VAL THR GLN TRP CYS GLU GLY SER SER SEQRES 10 A 304 LEU TYR HIS HIS LEU HIS ILE ILE GLU THR LYS PHE GLU SEQRES 11 A 304 MET ILE LYS LEU ILE ASP ILE ALA ARG GLN THR ALA GLN SEQRES 12 A 304 GLY MET ASP TYR LEU HIS ALA LYS SER ILE ILE HIS ARG SEQRES 13 A 304 ASP LEU LYS SER ASN ASN ILE PHE LEU HIS GLU ASP LEU SEQRES 14 A 304 THR VAL LYS ILE GLY ASP PHE GLY LEU ALA THR VAL LYS SEQRES 15 A 304 SER ARG TRP SER GLY SER HIS GLN PHE GLU GLN LEU SER SEQRES 16 A 304 GLY SER ILE LEU TRP MET ALA PRO GLU VAL ILE ARG MET SEQRES 17 A 304 GLN ASP LYS ASN PRO TYR SER PHE GLN SER ASP VAL TYR SEQRES 18 A 304 ALA PHE GLY ILE VAL LEU TYR GLU LEU MET THR GLY GLN SEQRES 19 A 304 LEU PRO TYR SER ASN ILE ASN ASN ARG ASP GLN ILE ILE SEQRES 20 A 304 PHE MET VAL GLY ARG GLY TYR LEU SER PRO ASP LEU SER SEQRES 21 A 304 LYS VAL ARG SER ASN CYS PRO LYS ALA MET LYS ARG LEU SEQRES 22 A 304 MET ALA GLU CYS LEU LYS LYS LYS ARG ASP GLU ARG PRO SEQRES 23 A 304 LEU PHE PRO GLN ILE LEU ALA SER ILE GLU LEU LEU ALA SEQRES 24 A 304 ARG SER LEU PRO LYS SEQRES 1 B 304 MET ASP ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER SEQRES 2 B 304 GLU ASP ARG ASN ARG MET LYS THR LEU GLY ARG ARG ASP SEQRES 3 B 304 SER SER ASP ASP TRP GLU ILE PRO ASP GLY GLN ILE THR SEQRES 4 B 304 VAL GLY GLN ARG ILE GLY SER GLY SER PHE GLY THR VAL SEQRES 5 B 304 TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA VAL LYS MET SEQRES 6 B 304 LEU ASN VAL THR ALA PRO THR PRO GLN GLN LEU GLN ALA SEQRES 7 B 304 PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS THR ARG HIS SEQRES 8 B 304 VAL ASN ILE LEU LEU PHE MET GLY TYR SER THR LYS PRO SEQRES 9 B 304 GLN LEU ALA ILE VAL THR GLN TRP CYS GLU GLY SER SER SEQRES 10 B 304 LEU TYR HIS HIS LEU HIS ILE ILE GLU THR LYS PHE GLU SEQRES 11 B 304 MET ILE LYS LEU ILE ASP ILE ALA ARG GLN THR ALA GLN SEQRES 12 B 304 GLY MET ASP TYR LEU HIS ALA LYS SER ILE ILE HIS ARG SEQRES 13 B 304 ASP LEU LYS SER ASN ASN ILE PHE LEU HIS GLU ASP LEU SEQRES 14 B 304 THR VAL LYS ILE GLY ASP PHE GLY LEU ALA THR VAL LYS SEQRES 15 B 304 SER ARG TRP SER GLY SER HIS GLN PHE GLU GLN LEU SER SEQRES 16 B 304 GLY SER ILE LEU TRP MET ALA PRO GLU VAL ILE ARG MET SEQRES 17 B 304 GLN ASP LYS ASN PRO TYR SER PHE GLN SER ASP VAL TYR SEQRES 18 B 304 ALA PHE GLY ILE VAL LEU TYR GLU LEU MET THR GLY GLN SEQRES 19 B 304 LEU PRO TYR SER ASN ILE ASN ASN ARG ASP GLN ILE ILE SEQRES 20 B 304 PHE MET VAL GLY ARG GLY TYR LEU SER PRO ASP LEU SER SEQRES 21 B 304 LYS VAL ARG SER ASN CYS PRO LYS ALA MET LYS ARG LEU SEQRES 22 B 304 MET ALA GLU CYS LEU LYS LYS LYS ARG ASP GLU ARG PRO SEQRES 23 B 304 LEU PHE PRO GLN ILE LEU ALA SER ILE GLU LEU LEU ALA SEQRES 24 B 304 ARG SER LEU PRO LYS HET DFS A 801 27 HET DFS B 801 27 HETNAM DFS 2,6-DIFLUORO-N-(1H-IMIDAZO[4,5-B]PYRIDIN-6-YL)-3- HETNAM 2 DFS [(PROPYLSULFONYL)AMINO]BENZAMIDE FORMUL 3 DFS 2(C16 H15 F2 N5 O3 S) HELIX 1 1 GLN A 493 ARG A 506 1 14 HELIX 2 2 SER A 536 ILE A 543 1 8 HELIX 3 3 GLU A 549 LYS A 570 1 22 HELIX 4 4 LYS A 578 ASN A 580 5 3 HELIX 5 5 GLU A 586 LEU A 588 5 3 HELIX 6 6 ALA A 621 ARG A 626 1 6 HELIX 7 7 SER A 634 GLY A 652 1 19 HELIX 8 8 ASN A 661 ARG A 671 1 11 HELIX 9 9 PRO A 686 LEU A 697 1 12 HELIX 10 10 LYS A 700 ARG A 704 5 5 HELIX 11 11 LEU A 706 ARG A 719 1 14 HELIX 12 12 GLN B 493 ARG B 506 1 14 HELIX 13 13 SER B 536 ILE B 543 1 8 HELIX 14 14 GLU B 549 LYS B 570 1 22 HELIX 15 15 GLU B 586 LEU B 588 5 3 HELIX 16 16 SER B 607 GLN B 612 1 6 HELIX 17 17 ALA B 621 ARG B 626 1 6 HELIX 18 18 SER B 634 GLY B 652 1 19 HELIX 19 19 ASN B 661 ARG B 671 1 11 HELIX 20 20 PRO B 686 LEU B 697 1 12 HELIX 21 21 LYS B 700 ARG B 704 5 5 HELIX 22 22 LEU B 706 ARG B 719 1 14 SHEET 1 A 5 ARG A 462 GLY A 464 0 SHEET 2 A 5 THR A 470 LYS A 475 -1 O VAL A 471 N ILE A 463 SHEET 3 A 5 ASP A 479 MET A 484 -1 O VAL A 482 N TYR A 472 SHEET 4 A 5 ALA A 526 GLN A 530 -1 O ILE A 527 N LYS A 483 SHEET 5 A 5 PHE A 516 SER A 520 -1 N GLY A 518 O VAL A 528 SHEET 1 B 2 ILE A 582 HIS A 585 0 SHEET 2 B 2 THR A 589 ILE A 592 -1 O THR A 589 N HIS A 585 SHEET 1 C 4 THR B 470 LYS B 475 0 SHEET 2 C 4 ASP B 479 MET B 484 -1 O VAL B 482 N TYR B 472 SHEET 3 C 4 ALA B 526 GLN B 530 -1 O THR B 529 N ALA B 481 SHEET 4 C 4 PHE B 516 SER B 520 -1 N GLY B 518 O VAL B 528 SHEET 1 D 2 ILE B 582 HIS B 585 0 SHEET 2 D 2 THR B 589 ILE B 592 -1 O THR B 589 N HIS B 585 CISPEP 1 PRO A 490 THR A 491 0 -0.67 CISPEP 2 PRO A 492 GLN A 493 0 -9.07 CISPEP 3 PRO B 490 THR B 491 0 -0.29 CISPEP 4 PRO B 492 GLN B 493 0 -7.87 SITE 1 AC1 15 VAL A 471 ALA A 481 LYS A 483 LEU A 505 SITE 2 AC1 15 LEU A 514 ILE A 527 THR A 529 GLN A 530 SITE 3 AC1 15 TRP A 531 CYS A 532 GLY A 593 ASP A 594 SITE 4 AC1 15 PHE A 595 GLY A 596 LEU A 597 SITE 1 AC2 11 ALA B 481 LYS B 483 LEU B 505 LEU B 514 SITE 2 AC2 11 THR B 529 GLN B 530 TRP B 531 CYS B 532 SITE 3 AC2 11 GLY B 593 PHE B 595 GLY B 596 CRYST1 106.970 106.970 152.440 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009348 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009348 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006560 0.00000